Treatment Options for Different Types of Pain in General Practice in India
Paracetamol (Calpol) and Ibuprofen (Brufen) are the cornerstone medications for managing mild to moderate pain in general practice in India, with selection based on pain intensity, patient characteristics, and underlying cause.
Pain Assessment and Classification
Pain should be assessed using standardized tools like:
- Numerical Rating Scale (NRS): 1-10 scale
- Pain categorization:
- Mild pain: NRS 1-4
- Moderate pain: NRS 5-7
- Severe pain: NRS >7 1
Treatment Algorithm Based on Pain Intensity
Mild Pain (NRS 1-4)
First-line: Paracetamol (Calpol) 500-1000 mg every 6 hours, maximum 4000 mg/day 1, 2
- Preferred by 77% of general practitioners, 78.57% of consulting physicians, and 74% of surgeons in India 3
- Advantages: Minimal GI effects, safe in most patients
- Caution: Reduce dose in liver disease
Alternative: Ibuprofen (Brufen) 200-400 mg every 6-8 hours, maximum 2400 mg/day 1, 4
- Advantages: More effective than paracetamol for many pain conditions 5
- Caution: GI protection recommended for prolonged use
Moderate Pain (NRS 5-7)
First-line: Paracetamol + Tramadol combination 3
- Preferred by 77% of GPs, 87.5% of consulting physicians, and 80.3% of orthopedicians in India
- Dosage: Typically 325-500 mg paracetamol with 37.5-50 mg tramadol
Alternative: Paracetamol + Ibuprofen combination 6
Severe Pain (NRS >7)
First-line: Strong opioids (e.g., morphine) + non-opioid analgesics 1, 2
- Starting dose: Oral morphine 20-40 mg/day divided every 4 hours
- Should include breakthrough pain medication (10-15% of total daily dose)
Alternative: Transdermal fentanyl for stable pain 1, 2
- Not recommended as first-line for patients who can swallow
- Useful for patients with poor compliance or inability to take oral medications
Pain-Specific Treatment Approaches
Neuropathic Pain
First-line: Gabapentin 1
- Titrate to 2400 mg per day in divided doses
- Brand names in India: Gabapin, Gabtin, Neurontin
Second-line options:
Topical therapy: Capsaicin cream for peripheral neuropathic pain 1
Musculoskeletal Pain
- Ibuprofen (Brufen) 400 mg three times daily
- Diclofenac (Voveran) 50 mg three times daily
- Naproxen (Naprosyn) 250-500 mg twice daily
For chronic conditions: Consider cyclooxygenase-2 (COX-2) inhibitors with caution 1
Cancer Pain
Follow WHO analgesic ladder 1, 2:
- Step 1 (Mild pain): Non-opioid analgesics
- Step 2 (Moderate pain): Weak opioids + non-opioids
- Step 3 (Severe pain): Strong opioids + non-opioids
Important Considerations for Analgesic Selection
Patient Factors to Consider
Age: Most important factor cited by 72.8% of GPs, 74.4% of dentists, and 87.5% of consulting physicians 3
- Elderly: Start with lower doses, especially of opioids and NSAIDs 2
Duration of therapy: Critical factor for 70.8% of GPs and 73.6% of surgeons 3
- Short-term: Standard dosing
- Long-term: Consider side effect profiles, add gastroprotection with NSAIDs
Comorbidities:
Common Pitfalls to Avoid
Overreliance on OTC medications: 68% of Indian patients self-medicate with OTC drugs, primarily NSAIDs (95%) 8
Inadequate pain specialist referral: 38.8% of practitioners cite lack of pain clinics as reason for not referring patients 3
Inadequate breakthrough pain management: Ensure rescue doses (10-15% of total daily opioid dose) are prescribed 2
Neglecting non-pharmacological approaches: Consider physical therapy, heat therapy, and other modalities 2
Brand Names of Common Pain Medications in India
Paracetamol
- Calpol (GlaxoSmithKline)
- Dolo (Micro Labs)
- Paracip (Cipla)
- Febrinil (Alkem)
NSAIDs
- Brufen (Abbott) - Ibuprofen
- Voveran (Novartis) - Diclofenac
- Combiflam (Sanofi) - Ibuprofen + Paracetamol
- Naprosyn (RPG Life Sciences) - Naproxen
Opioids
- Tramadol brands: Tramazac, Tramacip
- Combination brands: Ultracet (Tramadol + Paracetamol)
Neuropathic Pain Medications
- Gabapentin: Gabapin, Gabtin, Neurontin
- Pregabalin: Pregeb, Lyrica, Pregabalin
- Duloxetine: Duzela, Dulane, Cymbalta